Internet Based Cognitive Behavior Treatment for Alcohol Use Disorders (ICBT-AUD)

June 23, 2020 updated by: Anne H Berman, Karolinska Institutet

Internet Based Cognitive Behavior Treatment for Alcohol Use Disorders - a Randomized Controlled Trial

The purpose of this study is to determine whether extensive internet based cognitive behavior treatment program with guidance is a more effective method to treat individuals with alcohol use disorders than a briefer cognitive behavior treatment program without guidance.

Study Overview

Detailed Description

Two Internet based programs based on cognitive behavioral therapy and relapse prevention are evaluated among Internet help seekers, and compared to a waiting list. The design is a three armed randomized controlled trial, and outcomes are measured in terms of changes in alcohol consumption (mean consumption/week, number of heavy drinking days/week), problematic alcohol use, self efficacy, craving, as well as depression, anxiety and quality of life. In addition to this, the following instruments will be used as predictors: ASRS (ADHD), Hp5i (personality assessment). TIC-P, an instrument measuring cost effectiveness will also be used. Treatment Credibility and Adverse Events will also be assessed, the former once during the third week of treatment, and the latter once half way through treatment and once after treatment.

Primary hypothesis is that the more extended program with guidance (group 1) is more effective in reducing mean alcohol consumption and number of heavy drinking days compared to the briefer program with no guidance (group 2), as well as compared to a waiting list (group 3). A responder to treatment is defined as a participant drinking less than 9 (women)/ 14(men) glasses per week and no more than 3 (women)/4 (men) glasses per drinking day during that week.

A minimum of 169 participants will be recruited in two phases: first through an online screening and then through a diagnostic telephone assessment, where SCID will be used to diagnose Alcohol Use Disorders and MINI will be used to diagnose other psychiatric diagnoses. The telephone assessment and all guidance will be conducted by licensed psychologists or master students in psychology under supervision by licensed psychologists.

Included participants will be randomized into three groups:

Group 1: All participants in this group will have access to an extended cognitive behavioral treatment program and have access to a guide with basic training in psychotherapy (CBT) who assists and counsels the participant throughout the program.

Group 2: Participants in this group will have access to a briefer cognitive behavior treatment program with no access to a guide.

Group 3: Participants in this group will be placed on a waiting list for 12 weeks. Thereafter, they will be given access to the same extended cognitive behavior treatment program as Group 1; they will also be offered a possibility to choose between three guidance options: Choice 1: guide with intensive support, Choice 2: guide with support only at request, Choice 3: no guide.

Interim analyses will be undertaken in May 2016 by graduate students in Clinical psychology writing their MSc theses.

Study Type

Interventional

Enrollment (Actual)

166

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 11364
        • Karolinska Institutet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ≥ 18 years
  • access to the internet
  • consumption of at least 9 (females)/14 (males) glasses of alcohol during the preceding week
  • AUDIT ≥ 14 for females, ≥ 16 for men
  • have an Alcohol Use Disorder according to the DSM-5 (i.e., at least 2 out of 11 criteria)

Exclusion Criteria:

  • insufficient Swedish skills
  • reading or writing difficulties, if it is to a degree that it will hamper the treatment
  • concurrent other psychological treatment with a content resembling treatments in this study
  • severe depression defined as a score of more than 30 on the MADRS-S
  • suicide-risk defined as more than 4 points on the MADRS-S question 9, or based on the structured interview
  • Drug use problems defined as ≥ 8 p on the DUDIT
  • somatic or psychiatric disorders that are contraindicated for the treatment or impairs the ability to receive it (for example schizophrenia, bipolar disease, PTSD)
  • has during the last 3 weeks begun medication for alcohol problems or other psychiatric disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Extended self-help program with guidance
The program is a comprehensive CBT program lasting 12 weeks, with as many modules. The modules are quite extensive. A guide with basic education in psychotherapy assists and counsels participants online.
See arm description for Experimental
Other Names:
  • ePlus with guidance
Active Comparator: Briefer Self-help program, no guidance
This self-help program also lasts 12 weeks but contains only 9 modules; a pause occurs during the final weeks of the program for self-testing of acquired skills. The modules are quite brief. Participants receive no guidance.
See arm description for Active Comparator
Other Names:
  • eChange
Other: WL: Extended self-help program, choice of guidance intensity
Participants will be put on a waiting list. After 12 weeks on the waiting list, participants will receive access the the extended self-help program used in the experimental arm. However, participants will be offered a choice between three guidance options of varying intensity: proactive guidance, reactive guidance (only at participant request) or no guidance.
See arm description for Waiting list.
Other Names:
  • ePlus with choice of guidance intensity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time Line Follow Back
Time Frame: Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment
Number of standard drinks during preceding week (using the Time Line Follow Back)
Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment
Time Line Follow Back
Time Frame: Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment
Days of heavy drinking during preceding week (using the Time Line Follow Back)
Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol Use Disorders Identification Test
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
assessement of alcohol use problems
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Alcohol Abstinence Self Efficacy Scale
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
instrument measuring self-efficacy
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Penn Alcohol Craving Scale
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
instrument measuring craving for alcohol
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Montgomery Asberg Depression Rating Scale
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
instrument measuring depression
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Euro-QOL 5 D
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
instrument measuring quality of life
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Generalized Anxiety Disorder-7
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
instrument measuring anxiety
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Trimbos and iMTA questionnaire on cCosts associated with Psychiatric illness (TiC-P)
Time Frame: Screening, 12 months, 24 months post-treatment
Instrument measuring health care consumption and cost-effectiveness (Bouwmans et al., 2013
Screening, 12 months, 24 months post-treatment
Self-report questionnnaire on satisfaction with internet treatment usability features
Time Frame: Post-treatment (12 weeks after before-treatment measure)
This instrument contains 40 questions about satisfaction with various features of the internet-based treatment. Results will be analyzed on an aggregated group level. The questionnaire was constructed by the Internet psychiatry clinic in Stockholm.
Post-treatment (12 weeks after before-treatment measure)
Adult ADHD Self Report Scale (ASRS)
Time Frame: Screening
Screening of ADHD symptoms to be used as predictor of treatment outcome
Screening
Health-relevant Personality traits from a Five-factor perspective (hp5i)
Time Frame: Screening
Screening of personality traits to be used as predictor of treatment outcome
Screening
Adverse Events
Time Frame: Halfway through treatment (6 weeks after before-treatment measure) and post-treatment (12 weeks after before-treatment measure)
Brief questionnaire with questions about any negative side effects of the treatment
Halfway through treatment (6 weeks after before-treatment measure) and post-treatment (12 weeks after before-treatment measure)
Treatment Credibility Scale
Time Frame: 3 weeks after before-treatment measure
Brief questionnaire about if the treatment this far is perceived as effective
3 weeks after before-treatment measure
SCID- section of Alcohol Use Disorders (adjusted to DSM5)
Time Frame: Screening interview, 12 and 24 months post-treatment
Diagnostic interview via telephone, diagnostic criteria of Alcohol Use Disorders (this will be undertaken if resurces allow). This will be a masked assessment, the interviewer will not know which original group the participant was randomized to
Screening interview, 12 and 24 months post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Anne H Berman, PhD, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2016

Primary Completion (Actual)

June 1, 2019

Study Completion (Actual)

June 1, 2019

Study Registration Dates

First Submitted

January 2, 2016

First Submitted That Met QC Criteria

January 2, 2016

First Posted (Estimate)

January 5, 2016

Study Record Updates

Last Update Posted (Actual)

June 25, 2020

Last Update Submitted That Met QC Criteria

June 23, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Use Disorders

Clinical Trials on Extended self-help program with guidance

Subscribe